(Q44644323)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21553005%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

title

Neuroanatomical targets of reboxetine and bupropion as revealed by pharmacological magnetic resonance imaging (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21553005%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21553005%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Andrew M. Blamire

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21553005%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Annemie Van der Linden

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21553005%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

author name string

Sakthivel Sekar

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21553005%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

J Van Audekerke

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21553005%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

G Vanhoutte

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21553005%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

T Steckler

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21553005%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

M Shoaib

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21553005%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Marleen Verhoye

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21553005%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

publication date

7 May 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21553005%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21553005%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

volume

217

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21553005%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21553005%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

page(s)

549-557

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21553005%20AND%20SRC:MED&resulttype=core&format=json

A role for fMRI in optimizing CNS drug development

31 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2311-7

Serotonergic and noradrenergic modulation of emotion processing by single dose antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2311-7

Noradrenaline in mood and anxiety disorders: basic and clinical studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2311-7

Differential inhibition of lysophosphatidate signaling by volatile anesthetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2311-7

The neural substrates of affective processing in depressed patients treated with venlafaxine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2311-7

Noradrenergic signaling in the amygdala contributes to the reconsolidation of fear memory: treatment implications for PTSD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2311-7

Examination of the Role of the Cerebral Cortex in the Perception of Pain Using Functional Magnetic Resonance Imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2311-7

Modification of norepinephrine and serotonin, but not dopamine, neuron firing by sustained bupropion treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2311-7

Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2311-7

Sustained administration of bupropion alters the neuronal activity of serotonin, norepinephrine but not dopamine neurons in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2311-7

Artifacts due to stimulus correlated motion in functional imaging of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2311-7

Antidepressant drug action: a neuropsychological perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2311-7

Suppression of vascular artifacts in functional magnetic resonance images using MR angiograms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2311-7

Role of presynaptic alpha2-adrenoceptors in antidepressant action: recent findings from microdialysis studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2311-7

Chronic treatment with reboxetine by osmotic pumps facilitates its effect on extracellular noradrenaline and may desensitize alpha(2)-adrenoceptors in the prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2311-7

Pharmacological magnetic resonance imaging: a new application for functional MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2311-7

Functional magnetic resonance neuroimaging of drug dependence: naloxone-precipitated morphine withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2311-7

A method for removing global effects in small-animal functional MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2311-7

Acute and chronic effects of desipramine and clorgyline on alpha(2)-adrenoceptors regulating noradrenergic transmission in the rat brain: a dual-probe microdialysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2311-7

Diminished neural processing of aversive and rewarding stimuli during selective serotonin reuptake inhibitor treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2311-7

Single dose antidepressant administration modulates the neural processing of self-referent personality trait words

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2311-7

Contrasting Fos expression induced by acute reboxetine and fluoxetine in the rat forebrain: neuroanatomical substrates for the antidepressant effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2311-7

The effects of reboxetine on emotional processing in healthy volunteers: an fMRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2311-7

Noradrenergic enhancement of amygdala responses to fear

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2311-7

Effects of acute and chronic reboxetine treatment on stress-induced monoamine efflux in the rat frontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2311-7

A meta-analysis of clinical trials comparing reboxetine, a norepinephrine reuptake inhibitor, with selective serotonin reuptake inhibitors for the treatment of major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2311-7

Detection of pharmacologically mediated changes in cerebral activity by functional magnetic resonance imaging: the effects of sulpiride in the brain of the anaesthetised rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2311-7

Studies on the acute and chronic effects of reboxetine on extracellular noradrenaline and other monoamines in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2311-7

Neuroimaging studies of mood disorder effects on the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2311-7

Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2311-7

Imaging localised dynamic changes in the nucleus accumbens following nicotine withdrawal in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2311-7

The noradrenergic system in pathological anxiety: a focus on panic with relevance to generalized anxiety and phobias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2311-7

Effect of the selective noradrenergic reuptake inhibitor reboxetine on the firing activity of noradrenaline and serotonin neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2311-7

Noradrenaline systems in the hypothalamus, amygdala and locus coeruleus are involved in the provocation of anxiety: basic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2311-7

Differential effects of serotonergic and noradrenergic antidepressants on brain activity during a cognitive control task and neurofunctional prediction of treatment outcome in patients with depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2311-7

The role of fMRI in drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2311-7

Neuroadaptive responses to citalopram in rats using pharmacological magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2311-7

Acute treatment with antidepressant drugs selectively increases the expression of c-fos in the rat brain.

21 January 2018

1 reference

12 December 2020

Role of norepinephrine in the pathophysiology of neuropsychiatric disorders.

1 reference

12 December 2020

On the neural basis of fMRI signals

1 reference

12 December 2020

The efficacy of reboxetine as an antidepressant, a meta-analysis of both continuous (mean HAM-D score) and dichotomous (response rate) outcomes.

1 reference

12 December 2020

Behavioral correlates of negative BOLD signal changes in the primary somatosensory cortex

1 reference

12 December 2020

Effect of bupropion extended release on negative emotion processing in major depressive disorder: a pilot functional magnetic resonance imaging study.

1 reference

12 December 2020

Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study

1 reference

12 December 2020

A data post-processing protocol for dynamic MRI data to discriminate brain activity from global physiological effects.

1 reference

12 December 2020

Short-term antidepressant treatment and facial processing

1 reference

12 December 2020

Negative blood oxygen level dependence in the rat: a model for investigating the role of suppression in neurovascular coupling

1 reference

12 December 2020

Progressive attenuation of the firing activity of locus coeruleus noradrenergic neurons by sustained administration of selective serotonin reuptake inhibitors

1 reference

12 December 2020

Small animal, whole brain fMRI: innocuous and nociceptive forepaw stimulation

1 reference

12 December 2020

Review: reboxetine is ineffective and potentially harmful for acute treatment of major depression

1 reference

12 December 2020

Negative BOLD with large increases in neuronal activity

1 reference

12 December 2020